Search results for "Diabetes"


 
Results 51 - 60 of about 963 for "Diabetes".
Sort by: Relevance | Newest | Oldest

AI and IM, updates on weight loss drugs, and more

This issue includes cover stories on AI and GLP-1s for weight loss, as well as a feature on a new career development program and a preview of Internal Medicine Meeting 2024, among other stories.
https://immattersacp.org/archives/2024/03/ai-and-im-updates-on-weight-loss-drugs-and-more.htm
1 Mar 2024

Experts debate dilemmas in colorectal cancer screening

The latest ACP/Annals of Internal Medicine virtual forum discussed the controversy around colorectal cancer screening, clarified the rationale supporting the varying recommendations, and equipped physicians to make screening choices that best align with patients' clinical situations.
https://immattersacp.org/archives/2024/02/experts-debate-dilemmas-in-colorectal-cancer-screening.htm
1 Feb 2024

Tracheostomy tube shortage; fire risk with diabetes device

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/01/tracheostomy-tube-shortage-fire-risk-with-diabetes-device.htm
1 Jan 2023

Diabetes education programs show mixed results

Educational programs for patients with uncontrolled diabetes showed some success but overall had mixed results in three recent trials.
https://immattersacp.org/weekly/archives/2011/10/18/4.htm
18 Oct 2011

MKSAP Quiz: routine follow-up visit for diabetes and hyperlipidemia

A 59-year-old woman is evaluated during a routine follow-up visit. She was recently diagnosed with type 2 diabetes mellitus and hyperlipidemia. She feels well. Medications are metformin, atorvastatin, and aspirin. Following a physical exam and lab results, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/weekly/archives/2014/03/11/3.htm
11 Mar 2014

GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes

An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
https://immattersacp.org/weekly/archives/2021/12/21/2.htm
21 Dec 2021

Keep a close eye on the kidneys in diabetes

Screening and adherence to best prescribing practices offer two key ways to prevent or slow the progression of chronic kidney disease in patients with diabetes.
https://immattersacp.org/archives/2020/09/keep-a-close-eye-on-the-kidneys-in-diabetes.htm
1 Sep 2020

CGM decreased HbA1c levels, hypoglycemia in patients with type 2 diabetes

Two industry-supported studies of continuous glucose monitoring (CGM) found encouraging results in patients with type 2 diabetes, leading editorialists to call for broadened access to the technology in this population, particularly in primary care.
https://immattersacp.org/weekly/archives/2021/06/08/4.htm
8 Jun 2021

Managing patients with diabetes and heart failure

Good control of diabetes in the presence of heart failure includes appropriate HbA1c targets, metformin and comprehensive lifestyle change as first-line therapy, and a team approach.
https://immattersacp.org/archives/2019/11/managing-patients-with-diabetes-and-heart-failure.htm
1 Nov 2019

New Board Prep and Diabetes for the Internist ACP course recordings now available

The six-hour Diabetes for the Internist recording and the 41 lectures of the ACP Board Prep Course are available to ACP members and nonmembers, with an opportunity for ACP members to earn CME and MOC credit.
https://immattersacp.org/weekly/archives/2021/08/24/6.htm
24 Aug 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next